Artificial Intelligence to Measure Adherence to Oral Medication
Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication
1 other identifier
interventional
200
1 country
5
Brief Summary
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Nov 2020
Longer than P75 for phase_4
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedStudy Start
First participant enrolled
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 19, 2024
September 1, 2024
4 years
July 1, 2019
September 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Service Utilization Report Form
Provides participant utilization of psychiatric ER visits or psychiatric hospitalization
12 months
Study Arms (2)
Smartphone App
EXPERIMENTALartificial intelligence (AI) smartphone app to provide support for medication adherence
Usual Care
ACTIVE COMPARATORUsual care provided at CSC clinic
Interventions
artificial intelligence (AI) smartphone app to provide support for medication adherence
Eligibility Criteria
You may qualify if:
- Enrolled in a CSC program
- Prescribed an oral antipsychotic
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (5)
Citrus Health
Hialeah, Florida, 33012, United States
InterAct
Grand Rapids, Michigan, 49503, United States
InterAct of Michigan
Kalamazoo, Michigan, 49007, United States
Red Rock
Oklahoma City, Oklahoma, 73105, United States
Family and Children's Services
Tulsa, Oklahoma, 74315, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2019
First Posted
August 6, 2019
Study Start
November 20, 2020
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share